VSHP Webinar 

Thursday, December 16, 2021 – 12:00pm-1:00 pm

Tyrosine Kinase Inhibitors: Are You ABL to Handle the Complications?

Speaker:

Anastassia Blewett, PharmD
PGY2 Oncology Pharmacy Resident
University of Virginia Health System

Presentation Objectives for Pharmacists:

• 1.       Review BCR-ABL tyrosine kinase inhibitor (TKI) pharmacology and place in cancer therapy
• 2.       Identify complications associated with BCR-ABL TKIs
• 3.       Analyze approaches to managing patients presenting with BCR-ABL TKI toxicities.

Presentation Objectives for Pharmacy Technicians:

• 1.       Describe tyrosine kinase inhibitor (TKI) place in cancer therapy
• 2.       List complications associated with BCR-ABL TKIs

Accreditation:

Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1.0 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.

ACPE UAN:  0108-0000-21-051-L01-P; 0108-0000-21-051-L01-T

Activity type: Knowledge-based

This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20.

To register: https://us02web.zoom.us/webinar/register/WN_2-FBuE26RfuupjhhvNKCpA